-

Cardiovascular Systems, Inc. to Webcast Fiscal 2020 Second-Quarter Earnings Conference Call Wednesday, February 5

Live Webcast at 3:30 p.m. CT (4:30 p.m. ET)

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) will host a live webcast of its fiscal 2020 second-quarter conference call on Wednesday, February 5, 2020, at 3:30 p.m. CT (4:30 p.m. ET). CSI management will discuss results for its fiscal second quarter ended December 31, 2019, and its financial outlook. CSI will issue a post-market earnings release prior to the call on February 5, 2020.

To access the live webcast, go to the events section of CSI’s investor relations website, https://investors.csi360.com/events-and-presentations/events-calendar/default.aspx, on the day of the conference, and click on the webcast link. A webcast replay will be available beginning at 6:30 p.m. CT the same day.

To participate in the conference call, dial (833) 241-7255 and enter 8396268. Please dial in at least 10 minutes prior to the call.

About Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company’s orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart in a few minutes of treatment time and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. For additional information, please visit www.csi360.com.

Contacts

Cardiovascular Systems, Inc.
Jack Nielsen
(651) 202-4919
j.nielsen@csi360.com

Padilla
Matt Sullivan
(612) 455-1709
matt.sullivan@padillaco.com

Cardiovascular Systems, Inc.

NASDAQ:CSII

Release Versions

Contacts

Cardiovascular Systems, Inc.
Jack Nielsen
(651) 202-4919
j.nielsen@csi360.com

Padilla
Matt Sullivan
(612) 455-1709
matt.sullivan@padillaco.com

More News From Cardiovascular Systems, Inc.

Cardiovascular Systems, Inc. to Participate at Three Upcoming Investor Conferences

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management plans to present and host investor meetings at three upcoming conferences. Webcasts of each of the presentations will be made available on CSI’s website at https://investors.csi360.com/events-and-presentations/events-calend...

Cardiovascular Systems, Inc. Reports Fiscal 2020 Second-Quarter Financial Results

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today reported financial results for its fiscal second quarter, ended December 31, 2019. CSI’s fiscal 2020 second-quarter revenues were $68.3 million, an increase of $8.1 million, or 13.5%, from the second quarter of fiscal 2019. Gross profit margin was 7...
Back to Newsroom